Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings

[1]  L. Natarajan,et al.  The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review , 2007, Brain, Behavior, and Immunity.

[2]  M. Irwin,et al.  Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids , 2007, Brain, Behavior, and Immunity.

[3]  A. Cox,et al.  Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review , 2006, BMC Cancer.

[4]  M. Irwin,et al.  Inflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors , 2006 .

[5]  P. Ganz,et al.  Fatigue in long‐term breast carcinoma survivors , 2006, Cancer.

[6]  G. Heinze,et al.  Interleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women , 2005, Clinical Cancer Research.

[7]  Andrew H. Miller,et al.  Promoter Polymorphisms of the Interferon-α Receptor Gene and Development of Interferon-Induced Depressive Symptoms in Patients with Chronic Hepatitis C: Preliminary Findings , 2005, Neuropsychobiology.

[8]  J. Yarnold,et al.  TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  P. Ganz,et al.  Altered Cortisol Response to Psychologic Stress in Breast Cancer Survivors With Persistent Fatigue , 2005, Psychosomatic medicine.

[10]  S. Dickerson,et al.  Diurnal cortisol rhythm and fatigue in breast cancer survivors , 2005, Psychoneuroendocrinology.

[11]  A. Bateman,et al.  Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. , 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[12]  B. Weber,et al.  Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer. , 2003, Cancer research.

[13]  P. Ganz,et al.  T-cell homeostasis in breast cancer survivors with persistent fatigue. , 2003, Journal of the National Cancer Institute.

[14]  Patricia A. Ganz,et al.  Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors , 2002, Psychosomatic medicine.

[15]  F. Burzotta,et al.  Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. , 2001, The American journal of cardiology.

[16]  A. Rumley,et al.  Interleukin-6 Gene −174G>C and −572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[17]  T. Pollmächer,et al.  Cytokine-associated emotional and cognitive disturbances in humans. , 2001, Archives of general psychiatry.

[18]  P. Ganz,et al.  Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[20]  P. Jacobsen,et al.  A multidimensional measure of fatigue for use with cancer patients. , 1998, Cancer practice.

[21]  J. Bidwell,et al.  A novel NlaIII polymorphism in the human IL-6 promoter. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[22]  A. Blakemore,et al.  Single base polymorphism at −511 in the human interleukin-1β gene (IL1β) , 1992 .

[23]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[24]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[25]  P. Jacobsen,et al.  Further validation of the multidimensional fatigue symptom inventory-short form. , 2004, Journal of pain and symptom management.

[26]  C. Holmes,et al.  Association between interleukin 1‐β promoter (−511) polymorphism and depressive symptoms in Alzheimer's disease , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[27]  R. Dantzer,et al.  Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.